The present invention relates to methods of treating or preventing an inflammatory or immune disorder in a subject while eliminating or reducing the toxicity associated with the administration of cyclosporin A, comprising systemically administering to said subject a pharmaceutical composition comprising a therapeutically effective amount of at least one compound of Formula (I) or a pharmaceutically acceptable salt, ester or prodrug thereof, in combination with a pharmaceutically acceptable carrier or excipient: ##STR1##

in Formula (I), the formula for residue A is: ##STR2##


< Isolation and cultivation of microorganisms from natural environments and drug discovery based thereon

< TNF receptor and steroid hormone in a combined therapy

> Cyclosporins for the treatment of immune disorders

> Treatment of retrovirus induced derangements with niacin compounds

~ 00245